Celon Pharma S.A. Overview
Pro stress-test →Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs, serving as a successful marketing authorisation holder for its products. The company offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders.
Strategic Profile
Pro stress-test →The company has a strong research and development base that allows it to create completely new classes of effective medicines. During the last 5 years, Celon has delivered 6 successful data readouts, initiated 11 clinical trials, and raised capital through EU-funded financings and public offerings.
Competitive Landscape
Pro stress-test →Celon competes against larger pharmaceutical manufacturers including Pfizer Manufacturing Austria, Glenmark Pharmaceuticals, and GlaxoSmithKline Consumer Nigeria. As a smaller specialized player, Celon focuses on niche therapeutic areas (oncology, neurology, diabetes) rather than direct competition with global pharma giants.
Industry Context
Celon Pharma S.A. operates in Pharmaceuticals - Specialty & Generic.
Key facts
Founded: 2002 · Headquarters: Lomianki, Poland · Employees: 568 · Revenue: $48.9M · Market cap: $348M